EFL026 - RAI for Metastatic Thyroid Cancer

episode

Endocrine Feedback Loop not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Legal AF 9/26/2026 1h 26m · 27 Sep 2026 · Legal AF by MeidasTouch

Trump Cuts Trip Short as Iran Tensions and Political Pressure Mount 16 min · 27 Sep 2026 · The MeidasTouch Podcast

The Interviews | Ari Emanuel, Tom Morello, Jessica Tarlov, Merritt Wever 1h 19m · 27 Sep 2026 · The Daily Show: Ears Edition

Massachusetts Took Their Daughter After They Refused To Affirm Her Gender 14 min · 27 Sep 2026 · Morning Wire

Always in Blossom | Joel Osteen 30 min · 27 Sep 2026 · Joel Osteen Podcast

NPR News: 09-27-2026 4AM EDT 5 min · 27 Sep 2026 · NPR News Now

Report any issue

Source

Recorded16 Jun 2022

Publisherendocrine.org ↗

Handlerec:14756657

Show notes

Join host Chase Hendrickson, MD, from Vanderbilt Unviersity Medical Center as he discusses a recent article in Journal of the Endocrine Society (JES) with Imali Sirisena, MD, from Temple University and Mike Tuttle, MD, from Memorial Sloan Kettering Cancer Center. The article is from the March 2022 edition of JES: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for 131I Administration.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/journals/endocrine-feedback-loop-podcast-series

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in